BioSpace News Archive

Repare Therapeutics Inc. today announced that the Company has received an approximately $1.5 million (¥200 million) research service payment from Ono Pharmaceutical Co., Ltd. (“Ono”).

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its targets to reduce greenhouse gas (GHG) emissions have been approved by the Science Based Targets initiative (SBTi), providing external validation of the Company’s ambitious commitments to minimize its environmental footprint.

AVAIL SCIENTIFIC (OTC PINK: MOBO ) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which provides Neurological testing and data management.

Sunshine Biopharma Inc. today announced its board of directors has authorized a share repurchase program to acquire up to $2 million of the Company’s common stock.

Bellicum Pharmaceuticals, Inc. today announced that an abstract on early results from a Phase 1 clinical trial for BPX-601, its lead GoCAR-T ® product candidate, has been accepted for poster presentation at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU).

iSpecimen Inc. today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023.

Zhongchao Inc. today announced that Zhongxin Medical Technology Co., Ltd. (“Zhongxin”), one of the China operating entities of which the Company consolidates the financial results with through certain contractual arrangements, launched the Medication Management Assistance Mini Program on WeChat.

Soligenix, Inc. announced today that it will be presenting at the upcoming Virtual Investor Summit on January 26, 2023. The presentation will take place at 9:00 AM ET.

Palatin today announced the initiation of a Phase 2b clinical trial with the melanocortin agonist, bremelanotide.

Novocure (NASDAQ: NVCR) today announced organizational changes to prepare for future growth, effective Jan. 17.